IRIS
ROSSI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.612
AS - Asia 3.715
EU - Europa 3.029
SA - Sud America 593
AF - Africa 161
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
Totale 12.126
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.503
SG - Singapore 1.500
CN - Cina 1.279
IE - Irlanda 571
SE - Svezia 512
BR - Brasile 495
FI - Finlandia 451
IT - Italia 425
HK - Hong Kong 320
DE - Germania 294
UA - Ucraina 246
VN - Vietnam 244
NL - Olanda 143
TR - Turchia 131
ZA - Sudafrica 122
GB - Regno Unito 78
FR - Francia 76
CA - Canada 69
RU - Federazione Russa 61
IN - India 54
AR - Argentina 44
AT - Austria 44
BE - Belgio 34
ID - Indonesia 29
MX - Messico 28
ES - Italia 27
KR - Corea 27
IQ - Iraq 22
CZ - Repubblica Ceca 21
JP - Giappone 18
EC - Ecuador 16
BD - Bangladesh 15
PL - Polonia 15
PY - Paraguay 10
EU - Europa 9
MA - Marocco 9
PE - Perù 9
AE - Emirati Arabi Uniti 7
EG - Egitto 7
MY - Malesia 7
PK - Pakistan 7
JO - Giordania 6
UZ - Uzbekistan 6
AU - Australia 5
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
DZ - Algeria 5
KE - Kenya 5
KZ - Kazakistan 5
PT - Portogallo 5
SA - Arabia Saudita 5
CI - Costa d'Avorio 4
CR - Costa Rica 4
IR - Iran 4
LT - Lituania 4
NP - Nepal 4
RO - Romania 4
VE - Venezuela 4
BY - Bielorussia 3
CH - Svizzera 3
IL - Israele 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AM - Armenia 2
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
LB - Libano 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 12.126
Salva come PNG Salva come JPEG
Città #
Singapore 777
Ashburn 653
Chandler 613
Dublin 569
Santa Clara 396
Beijing 318
Hong Kong 316
Jacksonville 310
Dallas 239
Dearborn 212
Ann Arbor 162
Boardman 150
Nanjing 131
Parma 125
Johannesburg 111
Izmir 104
Princeton 103
Ho Chi Minh City 89
Los Angeles 88
Shanghai 85
Wilmington 76
San Mateo 71
Hefei 68
Helsinki 64
Shenyang 61
Nanchang 59
Munich 57
Columbus 50
Hanoi 50
New York 48
Toronto 45
Bremen 40
São Paulo 40
Seattle 38
Milan 37
Moscow 35
Hebei 34
Brussels 33
Buffalo 33
The Dalles 33
Vienna 33
Jinan 32
Woodbridge 32
Council Bluffs 31
Guangzhou 30
Bologna 29
Brooklyn 27
Changsha 26
Jiaxing 26
Kunming 26
Seoul 25
Tianjin 24
Jakarta 22
Des Moines 19
San Jose 19
Brno 18
Houston 17
Rio de Janeiro 17
Tokyo 16
Amsterdam 15
Falls Church 15
Norwalk 15
Turku 14
Fremont 13
London 13
Phoenix 13
Turin 13
Grafing 12
Rome 12
Brasília 11
Chicago 11
Orem 11
Stockholm 11
Zhengzhou 11
Denver 10
Frankfurt am Main 10
Nuremberg 10
Taizhou 10
Warsaw 10
Ankara 9
Belo Horizonte 9
Boston 9
Campinas 9
Haiphong 9
Hangzhou 9
Montreal 9
Poplar 9
Atlanta 8
Da Nang 8
Dong Ket 8
Padova 8
Pune 8
Baghdad 7
Manchester 7
Mexico City 7
San Francisco 7
Borås 6
Charlotte 6
Curitiba 6
Ferrara 6
Totale 7.396
Salva come PNG Salva come JPEG
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 223
Opportunity and challenges of nasal powders: Drug formulation and delivery 179
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 167
Agglomerated Oral Dosage Forms of Artemisinin/β-cyclodextrin Spray-dried Primary Microparticles Showing Increased Dissolution Rate and Bioavailability 165
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 164
MULTILAYERED PHARMACEUTICAL FORMULATION 160
Alginate containing formulations: are they all the same? 159
GASTRO-RESISTANT DELAYED RELEASE PHARMACEUTICAL FORM 150
Clyndamicin-Artesunate Combined Multi-Kinetics Drug Delivery System for Malaria Theraphy 144
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 143
Characterization of a polyurethane-based controlled release system for local delivery of chlorhexidine diacetate 143
Chimerical agglomerates of lecithin/chitosan nanoparticles for powder nasal delivery 142
Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release 141
Aerodynamic performance of jet nebulizers marketed in Germany 140
Cell culture studies of polysaccharide films loaded with cisplatin for the loco-regional therapy of malignant pleural mesothelioma 140
A new assembled delivery system of Clarithromycin and Amoxicillin for Helicobacter Pylori therapy 139
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 139
BIOAVAILABILITY OF ARTEMISININ-β-CYCLODEXTRIN COMPLEX FORMULATED AS SOFT AGGLOMERATES 138
Sex-specific cardiac electrophysiological remodeling influences the susceptibility to arrhythmias in elderly rats 137
Progesterone loading in lecithin/chitosan nanoparticles for transmucosal delivery 137
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 136
Chlorhexidine Salt-Loaded Polyurethane Orthodontic Chains: In Vitro Release and Antibacterial Activity Studies 135
Assemblage of drug release modules: Effect of module shape and position in the assembled systems on floating behavior and release rate 134
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 134
Thermal degradation and melting point determination of diclofenac 131
Assembled delivery modules for clarithromycin release in Helicobacter Pylori therapy 130
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 130
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitors 129
PROGESTERONE LOADED LECITHIN/CHITOSAN NANOPARTICLES FOR TRANSMUCOSAL DELIVERY 128
Interaction of pharmaceutical hydrates with supoercritical CO2: solubility, solid state and chemical modifications 127
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 125
Development of solid lipid microparticles by melt-emulsification/spray-drying processes as carriers for pulmonary drug delivery 125
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 122
Thermal Properties of Binary Mixtures of b-Cyclodextrin with Carbamazepine Polymorphs 120
Current status of ATP-ase proton pump inhibitor complexation with cyclodextrins 119
Lecithin-chitosan nanoparticles for transmucosal delivery of progesterone via chimerical agglomerates 118
Assembled delivery system for the release of two pulses of esomeprazole in combination with sucralfate 117
Therapeutic Paint of Cidofovir/Sucralfate Gel Combination Topically Administered by Spraying for treatment of Orf Virus Infections 117
COMPOSITION IN POWDER FORM MADE OF SOFT AGGLOMERATES OF A MICRONIZED DRUG AND TWO-COMPONENTS EXCIPIENTS, AND PROCESS FOR THEIR PREPARATION 116
Thermal and Morfological characterisation of micronized acetylsalicylic acid powders prepared by rapid expansion of a supercritical solution 115
FLOTATION OF DOSAGE FORMS AND DEVICES FOR SITE SPECIFIC THERAPY 115
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 114
Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide 113
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 112
Development and validation of a DESI-HRMS/MS method for the fast profiling of esomeprazole and its metabolites in rat plasma: a pharmacokinetic study. 112
Primary microparticles and agglomerates of morphine for nasal insufflation 111
Layered lipid microcapsules for mesalazine delayed-release in children 107
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 107
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 107
Structural surface changes and inflammatory responses against alginate-based microcapsules after exposure to human peritoneal fluid 107
Dry powder inhalers: An overview of the in vitro dissolution methodologies and their correlation with the biopharmaceutical aspects of the drug products 107
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 106
In vitro comparison of medicinal products based on alginic acid claimed to protect the esophagus wall and physically prevent acid reflux 103
Swellable and rigid matrices: Controlled Release Matrices with Cellulose Ethers 103
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 102
Hesperidin Gastroresistant Microparticles by Spray-Drying: Preparation, Characterization, and Dissolution Profiles 102
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction 102
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 102
Polymorphism of rac-5,6-Diisobutyryloxy-2-Methylamino-1,2,3,4-Tetrahydro-Napthalene Hydrochloride (CHF 1035). I. Thermal, Spectroscopic, and X-ray Diffraction Properties 102
Inclusion Properties, Polymorphism and Desolvation Kinetics in aNew 2-Pyridyl Iminophenol Compound with 1D Nanochannels 101
Glycyrrhizic acid and its hydrolyzed metabolite 18β-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer 101
New salt of cysteamine for the preparation of highly respirable particles 101
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 100
Solid state characterization of paracetamol metastable polymorphs formed in binary mixtures with hydroxypropylmethylcellulose 98
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 98
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 98
High Respirable Insulin Dry Powder for Pulmonary Administration 96
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 96
Particles and powders: Tools of innovation for non-invasive drug administration 95
Soft agglomerates of mesalazine multiparticles for colonic delivery in pediatric patients 94
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 94
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 93
Lecithin/Chitosan Based Nanosystem for Tamoxifen Citrate Oral Delivery 93
Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets 93
New Farnesane Sesquiterpenes from Lactarius Porninsis 91
Polymorphism in Cocoa Butter Under Shear 91
Le Basi del Calcolo Farmaceutico 91
Bauhinia ungulata L.: Medicinal Utilization, Botanical Aspects, Biological Properties and Chemical Constitution Reported in the Literature 90
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 90
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 90
Phase diagrams in the binary system 89
Pantoprazole Cyclodextrin Inclusion Complexes 88
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 87
Pharmacokinetics evaluation of soft agglomerates for prompt delivery of enteric pantoprazole-loaded microparticles 87
Influence of tamoxifen citrate loading on lecithin/chitosan nanoparticles 86
Thermal behavior of paracetamol-polymeric excipients mixtures 86
Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia 84
Multi-kinetics and site-specific oral delivery system of artemether and clindamycin for malaria theraphy 84
Polymorphism of rac-5,6-diisobutyryloxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene hydrochloride (CHF 1035). I. Thermal, spectroscopic, and X-ray diffraction properties 84
Nasal Powders of Morphine Microcrystal Agglomerates 84
In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery 82
Quercetin Microspheres by Solvent Evaporation: Preparation, Characterization and Release Behavior 81
Conversion of carbamazepine polymorphs in supercritical CO2 80
The Development of Insulin Dry Powder Blends for Pulmonary Administration 79
Direct powder extrusion (DPE) 3D-printing of mini-tablets for preclinical studies in rodents 78
Acai Oil-Based Organogel Containing Hyaluronic Acid for Topical Cosmetic: In Vitro and Ex Vivo Assessment 78
Understanding and enhancing density distribution inside tableted Dome Matrix modules 78
New Protoilludane Sesquiterpenes from Lactarius Violascens” 76
Nasal Powders of Morphine Microcrystal Agglomerates 76
PURE INSULIN HIGHLY RESPIRABLE POWDERS FOR INHALATION 75
Totale 11.228
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.188
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.188
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 0 0 0 17 81 22 131 23 85 18
2021/2022603 11 13 11 28 25 25 78 89 27 42 47 207
2022/20232.160 222 246 146 167 189 236 20 142 706 19 52 15
2023/2024810 34 88 24 55 67 191 65 47 26 47 69 97
2024/20252.616 74 133 146 163 285 341 110 104 294 238 240 488
2025/20263.281 566 522 732 419 831 211 0 0 0 0 0 0
Totale 12.288